Delivery Order SPE2DB20D2014-SPE2DB25FA36G

Award Date 11/15/24
Potential Completion Date 11/18/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,101.54 firm fixed-price delivery order contract is for the supply of AMLODIPINE-OLMESARTAN 10-40 MG 30S, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of November 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, valued at $2,362.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. The IDC, valued at $999,999,999, serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award, with ID SPE2DX15D3404|SPE2DX25F0YCT, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,130.45 firm-fixed-price delivery order is for AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a cardiovascular medication. The contract has an ultimate completion date of October 28, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA). The $2,590.80 firm fixed-price delivery order is for the supply of AMLOD-VALSA-HCTZ 10-160-25 MG 30S, a cardiovascular medication, to support military healthcare programs. The award is not associated with a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,675.52, is a delivery order for the supply of AMLOD-VALSA-HCTZ 10-320-25 MG 30S medication. The contract does not have a set-aside designation, indicating it was an open competition. It is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,626.87 firm fixed-price delivery order is for the medication AMLOD-VALSA-HCTZ 10-160-12.5MG 30S, and has a completion date of November 5, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $3,908.65 firm fixed price delivery order is for the supply of AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a combination medication, to support military medical treatment programs and facilities. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $20,813.01 firm-fixed-price delivery order is for medical supplies, specifically AMLOD-VALSA-HCTZ 10-320-25 MG 30S. The contract has an ultimate completion date of May 9, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,064.26, is a Firm Fixed Price Delivery Order with a period of performance running through November 2024. The contract provides for the delivery of AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a pharmaceutical product, to support military healthcare programs. Amerisourcebergen is an established vendor for...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,897.80 firm fixed-price delivery order covers the supply of AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a medical product, with a completion date of December 26, 2023. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FA36G
    Delivery Order

This federal contract award, with ID SPE2DB20D2014|SPE2DB25FA36G, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,688.60 firm fixed-price delivery order is for the supply of AMLODIPINE-OLMESARTAN 5-40 MG 30S, a cardiovascular medication.

The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

In addition to the DLA contract, Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/20/25, 2:19 PM